NIDA Epidemiology Training Program

物质使用障碍是世界上导致残疾的主要原因之一，而且有所改善 需要采取战略来减轻他们的负担。该培训计划的目标是产生 下一代药物依赖流行病学家，他们可以通过进行 研究将促进我们对物质使用的病因学和自然历史的理解； 制定、实施和评估预防和控制药物使用的干预措施； 以及严格审查药物滥用服务和护理系统，以改善物质 滥用后果，包括艾滋病毒相关风险。最新的科学进步，如基因组学， 脑成像和信息学为加速这一发现提供了新的机会 将调查结果转化为公共卫生收益。这项培训计划将利用 约翰·霍普金斯大学的跨学科资源和外部合作 为学员提供领导多学科所需技能和经验的机构 利用这些新出现的机会并促进整体健康和 社区的福祉。学员将通过严格的课程计划来实现这一点， 研究学徒制和综合活动，为核心提供坚实的基础 精通药物依赖流行病学。该项目将包括7名博士后 学生和5名博士后研究员，由经验丰富的14名核心人员提供支持 学院和6个附属学院。受训人员将准备在 从事药物依赖流行病学和艾滋病毒研究的学术界，主要是在 公共卫生或医学院，在政府制定研究优先事项和 私营行业在地方、州、国家和国际各级的药物滥用政策 为制药公司以及非营利机构或非政府组织进行应用研究 倡导那些有药物使用障碍的人的政府组织。这次培训 该计划成功地培训了近20年的药物依赖流行病学家。这个 该项目的前主任威廉·拉蒂默博士最近过渡到了 佛罗里达大学的领导权被移交给了黛布拉·弗尔-霍尔登博士，她曾是一名dDet 博士后实习生。Furr-Holden博士现在是一位有专业知识的有成就的副教授 药物和酒精依赖流行病学、精神病学流行病学和预防科学。 在这场相互竞争的更新中，她准备在该项目丰富的传统基础上再接再厉，并领导该项目 将培养下一代药物依赖流行病学领导者的新方向 和艾滋病毒研究谁将推动该领域的传统研究的发病率和 药物滥用障碍的流行率(即描述性流行病学)，并推动研究 重点关注病因机制、有针对性的干预措施和服务交付(即分析 流行病学)。

Substance use disorders are among the leading causes of disability in the world, and improved strategies to reduce their burden are needed. The goal of this training program is to produce the next generation of drug dependence epidemiologists who can address this need by conducting research that will advance our understanding of the etiology and natural history of substance use; developing, implementing, and evaluating interventions to prevent and control substance use; and critically examining substance abuse services and systems of care to improve substance abuse outcomes including HIV-related risk. Recent scientific advances such as in genomics, brain imaging, and informatics present new opportunities for accelerating the discovery and translation of findings into public health gains. This training program will capitalize on the interdisciplinary resources at Johns Hopkins University and collaborations within outside institutions to provide trainees with the skills and experiences needed to lead multi-disciplinary research that takes advantage of these emerging opportunities and promotes overall health and well being of communities. Trainees will achieve this through a rigorous program of coursework, research apprenticeships, and integrative activities that provide a solid foundation in the core proficiencies of drug dependence epidemiology. The program will include 7 predoctoral students and 5 postdoctoral fellows who are supported by an experienced group of 14 Core Faculty and 6 Affiliate Faculty. The trainees will be prepared to assume leadership positions in academia carrying out drug dependence epidemiology and HIV research typically as faculty in Schools of Public Health or Medicine, in government formulating research priorities and substance abuse policy at the local, state, national, and international levels, in private industry conducting applied research for pharmaceutical companies, and in non-profit agencies or non- governmental organizations advocating for those with substance use disorders. This training program has successfully trained drug dependence epidemiologists for close to 20 years. The former Director of the program, Dr. William Latimer, recently transitioned to a new position at the University of Florida and leadership was transferred to Dr. Debra Furr-Holden, a former DDET pre-doctoral trainee. Dr. Furr-Holden is now an accomplished Associate Professor with expertise in drug and alcohol dependence epidemiology, psychiatric epidemiology and prevention science. In this competing renewal, she is poised to build on the rich tradition of the program and lead it in new directions that will prepare the next generation of leaders in drug dependence epidemiology and HIV research who will advance the field beyond traditional studies of the incidence and prevalence of substance abuse disorders (i.e., descriptive epidemiology) and drive research that focuses on etiologic mechanisms, targeted interventions, and delivery of services (i.e., analytic epidemiology).